Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0 Supply Disruption — Watson Laboratories Inc (Low
Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0 Supply Disruption — Watson Laboratories Inc (Low is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0; Manufacturer: Watson
| Drug name | Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0 |
|---|---|
| Manufacturer | Watson Laboratories Inc |
| Recall/Disruption reason | Impurities/Degradation Products: Out-of-specification results were obtained for a known impurities. |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-094-2013 |
| Initiation date | 20121213 |
| Quantity affected | 63,627 cartons |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →